Dose Adjustment Arithmetic for AUC Matching

Why AUC-Matching Dose Arithmetic Is Useful

A covariate-associated change in clearance predicts a change in exposure if the dose is held fixed. At a fixed dose and bioavailability, AUC is inversely proportional to clearance: a fractional clearance increase of \(x\) multiplies AUC by \(1/(1+x)\), a fractional decrease of \(x/(1+x)\). For example, a 20% clearance increase multiplies AUC by \(1/1.2 = 0.8333\), a 16.7% decrease—not a 20% decrease. The corresponding arithmetic asks a narrower question: what dose would produce the same AUC at the changed clearance?

This calculation translates a clearance contrast into a dose ratio. It is useful for quantifying the size of an exposure-compensating adjustment, but it does not establish that the adjustment should be made. The calculation depends on assumptions about linearity, bioavailability, and the dosing regimen, and AUC alone does not describe every clinically relevant feature of a concentration-time profile.

Definition: For linear pharmacokinetics with constant clearance \(CL\), bioavailability \(F\), and a dose \(D\), the AUC over a dosing interval at steady state is \(AUC_{\tau}=FD/CL\). For intravenous dosing, \(F=1\). An AUC-matching dose is a dose that gives the same AUC over the specified interval as a reference dose, under the stated model assumptions.

Deriving the Dose Ratio

At steady state, the amount of drug entering the systemic circulation during one dosing interval must equal the amount eliminated during that interval. For a dose \(D\) with bioavailability \(F\), the systemic amount entering is \(FD\). If clearance is constant over the interval, the eliminated amount is clearance multiplied by the integral of concentration over time, \(CL \times AUC_{\tau}\). Equating input and elimination gives:

FD=CL\times AUC_{\tau} \quad\Longrightarrow\quad AUC_{\tau}=\frac{FD}{CL}

This mass-balance argument applies at steady state for a periodic regimen: the amount in the body at the end of an interval equals the amount at the beginning, so there is no net accumulation over that interval. Under linear pharmacokinetics, the same dose–AUC proportionality also applies to the AUC after a single dose, with the relevant bioavailable dose and clearance.

Let \(D_{\mathrm{ref}}\) and \(CL_{\mathrm{ref}}\) describe a reference condition, and \(D_{\mathrm{new}}\) and \(CL_{\mathrm{new}}\) describe the condition with a different clearance. If bioavailability is unchanged and the goal is to match AUC over the same dosing interval, set the two AUC expressions equal:

\frac{F D_{\mathrm{ref}}}{CL_{\mathrm{ref}}} = \frac{F D_{\mathrm{new}}}{CL_{\mathrm{new}}} \quad\Longrightarrow\quad D_{\mathrm{new}} = D_{\mathrm{ref}}\frac{CL_{\mathrm{new}}}{CL_{\mathrm{ref}}}

Thus, the dose ratio equals the clearance ratio. If clearance is 20% higher, the dose calculated to match AUC is 20% higher, assuming \(F\) and the relevant regimen are unchanged. If bioavailability differs between conditions, the more general relation is:

D_{\mathrm{new}} = D_{\mathrm{ref}} \frac{CL_{\mathrm{new}}}{CL_{\mathrm{ref}}} \frac{F_{\mathrm{ref}}}{F_{\mathrm{new}}}

The units provide a useful check. Clearance has units of volume per time, dose has units of mass, and AUC has units of concentration multiplied by time. For example, \((\mathrm{mg})/(\mathrm{L}/\mathrm{h})\) is \(\mathrm{mg}\cdot\mathrm{h}/\mathrm{L}\), as required for AUC.

Worked Example: Increasing the Dose for Higher Clearance

Suppose a hypothetical patient receives 100 mg every 12 hours. The reference clearance is 5.0 L/h, and bioavailability is \(F=0.80\). A covariate contrast is associated with a clearance of 6.25 L/h. Calculate the dose that matches the reference AUC per interval, assuming linear pharmacokinetics and unchanged bioavailability.

First calculate the reference AUC over one interval:

AUC_{\tau,\mathrm{ref}} = \frac{0.80\times100\ \mathrm{mg}}{5.0\ \mathrm{L/h}} = 16.0\ \mathrm{mg}\cdot\mathrm{h/L}

The clearance ratio is \(6.25/5.0=1.25\). Therefore, the AUC-matching dose is:

D_{\mathrm{new}} = 100\ \mathrm{mg}\times\frac{6.25\ \mathrm{L/h}}{5.0\ \mathrm{L/h}} = 125\ \mathrm{mg}

Check the result directly:

AUC_{\tau,\mathrm{new}} = \frac{0.80\times125\ \mathrm{mg}}{6.25\ \mathrm{L/h}} = 16.0\ \mathrm{mg}\cdot\mathrm{h/L}

The two AUC values match. Both regimens use a 12-hour interval, so the corresponding average concentrations over the interval also match: \(16.0\ \mathrm{mg}\cdot\mathrm{h/L}/12\ \mathrm{h}=1.33\ \mathrm{mg/L}\). This is an arithmetic illustration, not a recommendation to give 125 mg.

Working From an Exposure Change Back to a Dose

The dose ratio can also be understood by first considering what happens if the dose is not changed. With the same dose and bioavailability, the ratio of AUCs is inversely proportional to the ratio of clearances:

\frac{AUC_{\tau,\mathrm{new}}}{AUC_{\tau,\mathrm{ref}}} = \frac{CL_{\mathrm{ref}}}{CL_{\mathrm{new}}}

The dose adjustment then multiplies the dose by the clearance ratio, reversing that exposure change. This is a useful independent check: if clearance increases by a factor of 1.25, unchanged-dose AUC falls to \(1/1.25=0.80\) of its former value, and increasing the dose by 1.25 restores the original AUC under the assumptions.

Worked Example: Reducing the Dose for Lower Clearance

In a hypothetical example, an oral dose of 300 mg is given every 24 hours. Bioavailability is \(F=0.75\), and reference clearance is 20 L/h. For a second condition, clearance is 16 L/h. Assume bioavailability is unchanged and pharmacokinetics remain linear.

The reference AUC per interval is:

AUC_{\tau,\mathrm{ref}} = \frac{0.75\times300\ \mathrm{mg}}{20\ \mathrm{L/h}} = 11.25\ \mathrm{mg}\cdot\mathrm{h/L}

If the dose remains 300 mg, the AUC in the second condition would be:

AUC_{\tau,\mathrm{new,\ unchanged\ dose}} = \frac{0.75\times300\ \mathrm{mg}}{16\ \mathrm{L/h}} = 14.0625\ \mathrm{mg}\cdot\mathrm{h/L} \approx14.06\ \mathrm{mg}\cdot\mathrm{h/L}

This is 1.25 times the reference AUC because \(20/16=1.25\). To match the reference AUC, calculate:

D_{\mathrm{new}} = 300\ \mathrm{mg}\times\frac{16\ \mathrm{L/h}}{20\ \mathrm{L/h}} = 240\ \mathrm{mg}

Substitution verifies the result: \(0.75\times240\ \mathrm{mg}/(16\ \mathrm{L/h})=11.25\ \mathrm{mg}\cdot\mathrm{h/L}\). The calculated dose is 20% lower than the reference dose, matching the 20% lower clearance. Whether such a dose is appropriate depends on considerations beyond this equality.

Using a Target AUC Directly

Sometimes the calculation starts from a specified target AUC rather than a reference dose. Rearranging the mass-balance equation gives the dose required at a given clearance:

D=\frac{AUC_{\tau,\mathrm{target}}\times CL}{F}

This expression makes the assumptions visible: for the same target AUC and bioavailability, the required dose is proportional to clearance. If the target is an average concentration over a dosing interval, then \(AUC_{\tau,\mathrm{target}}=C_{\mathrm{avg,target}}\tau\), where \(\tau\) is the interval length. A change in interval must therefore be handled explicitly when the target is expressed as an average concentration.

Worked Example: Calculating Doses From a Target AUC

Suppose a hypothetical target is an AUC of 45 mg·h/L per interval. Bioavailability is estimated to be 0.90. Calculate doses for a reference clearance of 4.0 L/h and a second clearance of 3.2 L/h.

For the reference clearance:

D_{\mathrm{ref}} = \frac{45\ \mathrm{mg}\cdot\mathrm{h/L}\times4.0\ \mathrm{L/h}}{0.90} = 200\ \mathrm{mg}

For the second clearance:

D_{\mathrm{new}} = \frac{45\ \mathrm{mg}\cdot\mathrm{h/L}\times3.2\ \mathrm{L/h}}{0.90} = 160\ \mathrm{mg}

The ratio is \(160/200=0.80\), equal to the clearance ratio \(3.2/4.0=0.80\). Checking directly, \(0.90\times160\ \mathrm{mg}/(3.2\ \mathrm{L/h})=45\ \mathrm{mg}\cdot\mathrm{h/L}\). The calculation matches the stipulated target mathematically; it does not establish that the target or dose is clinically suitable.

Assumptions, Checks, and Failure Modes

The ratio is simple because the model is simple. Before interpreting it, verify that the comparison uses compatible quantities and that the assumptions supporting proportionality are plausible.

Linear pharmacokinetics: clearance and bioavailability must not change with dose over the relevant range. Saturable elimination, dose-dependent absorption, or other nonlinearities can break the direct dose–AUC proportionality.
Comparable bioavailability: if \(F\) differs across groups, formulations, or administration conditions, the clearance ratio alone is insufficient. Use the \(F_{\mathrm{ref}}/F_{\mathrm{new}}\) term only when those bioavailability values are known and applicable.
Comparable clearance definitions: compare clearances expressed on the same basis, such as systemic clearance after accounting for bioavailability when appropriate. A clearance estimate from a model should correspond to the same population or individual contrast used in the calculation.
Same interval and exposure definition: the dose-ratio shortcut assumes the same dosing interval and asks to match AUC over the corresponding interval. If the interval or target average concentration changes, state the target explicitly and recalculate from it.
Stable conditions: the calculation assumes clearance and bioavailability are sufficiently stable over the interval and the regimen has reached the relevant steady-state pattern when using \(AUC_{\tau}\).

A practical arithmetic check has three parts: confirm that the clearance ratio is dimensionless, confirm that the calculated dose changes in the same direction as clearance when matching AUC, and substitute the dose back into \(FD/CL\). If clearance rises but the proposed AUC-matching dose falls, the ratio has likely been inverted.

A further limitation is that equal AUC does not imply identical concentration-time profiles. Peak concentration, trough concentration, time above a threshold, and concentration fluctuations can depend on absorption, distribution, elimination, and the dosing interval. In a one-compartment representation, for example, volume of distribution affects the concentration-time shape even though it does not appear in the steady-state AUC equation. Thus an AUC match is an exposure match for a particular summary, not a guarantee that all concentration measures match.

Comparison With Other Ways to Frame the Question

Approach	Question answered	What it does not establish
Hold dose fixed and compare AUC	How does exposure change under the clearance contrast?	Which dose should be used
Scale dose by the clearance ratio	What dose would match AUC under the stated assumptions?	Whether matching AUC is the right clinical objective
Change the dosing interval	How might exposure distribution over time change with a different regimen?	That the same peak, trough, or AUC follows automatically
Use concentration measurements and a pharmacokinetic model	What individual exposure or regimen is consistent with observed data and a specified target?	That the model, samples, or target are free of uncertainty

The first two approaches are algebraic summaries of the same linear relationship. Interval changes and concentration-guided approaches address additional regimen or patient information, but they require their own assumptions and data. None should be treated as interchangeable without stating the exposure measure and target.

Why the Calculation Is Not a Dosing Recommendation

An AUC-matching calculation answers a conditional mathematical question: if the clearance contrast is valid, pharmacokinetics are linear, bioavailability is unchanged, and the target is to preserve AUC, then this dose ratio preserves the model-predicted AUC. It does not determine whether the covariate effect is estimated precisely, whether the population contrast applies to a particular patient, or whether the chosen AUC is an appropriate therapeutic target.

A calculated amount may also be unavailable in an appropriate dosage form, may require an impractical regimen, or may produce an undesirable peak or trough even while matching AUC. Clinical decisions need to consider the therapeutic objective, uncertainty in the clearance estimate, available dosing options, safety, and the broader clinical context. The arithmetic is therefore best reported as an exposure-matching calculation with its assumptions, not as a stand-alone instruction to change a dose.

Common Mistake

Common mistake: “Clearance is 25% higher, so reduce the dose by 25% to compensate.” This moves the dose in the wrong direction. With unchanged \(F\), dose must increase in proportion to clearance to preserve AUC: \(D_{\mathrm{new}}/D_{\mathrm{ref}}=CL_{\mathrm{new}}/CL_{\mathrm{ref}}\). A higher clearance otherwise lowers AUC at a fixed dose. Always check the proposed dose by substituting it into \(AUC_{\tau}=FD/CL\).

Check Your Understanding

Answer each question, then compare with the solutions below.

A reference dose is 200 mg, reference clearance is 10 L/h, and a second condition has clearance 12 L/h. If bioavailability is unchanged, what dose matches AUC?
At a fixed dose and unchanged bioavailability, clearance falls from 8 L/h to 6 L/h. What is the ratio of the new AUC to the reference AUC?
A target AUC is 30 mg·h/L, clearance is 5 L/h, and \(F=0.75\). What dose corresponds to this target?
Name two assumptions needed for the simple dose-ratio calculation.
Does matching AUC guarantee matching peak and trough concentrations? Explain briefly.

Solutions. (1) \(D_{\mathrm{new}}=200\times(12/10)=240\) mg. The dose increases because clearance is higher. (2) \(AUC_{\mathrm{new}}/AUC_{\mathrm{ref}}=8/6=1.333\); at the same dose, the AUC is 1.333 times the reference AUC, or about 33.3% higher. (3) \(D=AUC_{\mathrm{target}}CL/F=(30\ \mathrm{mg}\cdot\mathrm{h/L})(5\ \mathrm{L/h})/0.75=200\) mg. (4) Any two of the following: linear pharmacokinetics over the dose range, unchanged bioavailability, comparable clearance definitions, the same interval and AUC target, and stable conditions. (5) No. AUC is an integrated exposure measure; peak and trough also depend on the concentration-time profile, including distribution, absorption, and dosing interval.